Search Results 1031-1040 of 20402 for hepatitis

  1. Cancer causes: Popular myths about the causes of cancer - Mayo Clinic

    Hepatitis B and hepatitis C are viruses that can be passed through unprotected sex and sharing needles. These viruses can cause liver cancer. Talk to your ...

  2. A Clinical Study To Test How Effective And Safe GLPG1690 Is For Subjects With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard Medical Treatment

    Positive blood testing for hepatitis B surface antigen (HBS Ag) or hepatitis C virus (antibody, confirmed by hepatitis C virus (HCV) RNA positivity). Note ...

  3. A Study of Adjuvant Pembrolizumab/Vibostolimab (MK-7684A) Versus Pembrolizumab for Resected High-Risk Melanoma in Participants With High-Risk Stage II-IV Melanoma (MK-7684A-010/KEYVIBE-010) - Mayo Clinic

    on anti-retroviral therapy (ART). - Participants who are hepatitis B surface antigen (HBsAg) positive are eligible if they have received hepatitis B virus (HBV) ...

  4. A Study to Compare the Effectiveness and Safety of JCAR017 to Standard of Care in Adult Subjects With High-risk, Transplant-eligible Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphomas - Mayo Clinic

    ... hepatitis B or C are permitted. Subjects positive for hepatitis B surface antigen and/or anti-hepatitis B core antibody with negative viral load are ...

  5. Treatment of IgG4-Related Disease With Revlimid and Rituximab - Mayo Clinic

    Presence of active infection that would interfere with therapy on this study, including positive serum hepatitis B surface antigen, HIV or active hepatitis ...

  6. Clinical Trials - IS-002 in Prostate Cancer

    Subject has known active hepatitis B virus (HBV) or hepatitis C virus (HCV) infection. 3. Subject has a known history of acute or chronic liver or kidney ...

  7. Gastroenterology and Hepatology - Doctors - Mayo Clinic

    ... hepatitis, Hepatopulmonary syndrome, Liver disease, Liver cancer, Hepatic encephalopathy. Show more areas of focus for Denise M. Harnois, D.O. ...

  8. Hepatobiliary Cancer SPORE Quarterly Newsletter - Mayo Clinic

    2024 Jan 3;16(1):225. doi: 10.3390/cancers16010225. PMID: 38201652; PMCID: PMC10778206. Racial and ethnic disparities in untreated patients with hepatitis C ...

  9. A Study to Evaluate the Effectiveness, Safety and Tolerability of Efgatigimod PH20 SC in Adults with Pemphigus - Mayo Clinic

    following conditions: Hepatitis B Virus, Hepatitis C Virus , HIV. 18. The participant has total immunoglobulin G (IgG) <6 g/L at screening. 19. The ...

  10. FT819 in Subjects With B-cell Malignancies - Mayo Clinic

    Positive serologic and polymerase chain reaction (PCR) test results for Hepatitis B (HBV) infection. Positive serologic and PCR test results for Hepatitis C ( ...